Shedding light in the controversial terminology for platelet-rich products: Platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet-leukocyte gel (PLG), preparation rich in growth factors (PRGF), classification and commercialism

Journal of Biomedical Materials Research - Part A

Volumn 95, Issue 4, 2010, Pages 1280-1282

  Ehrenfest, David M Dohan ^a,b   Bielecki, Tomasz ^c   Corso, Marco Del ^d,e   Inchingolo, Francesco ^f   Sammartino, Gilberto ^e  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LoB5 Foundation for Research   (France)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d Private Practice   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BATROXOBIN; FIBRIN; GROWTH FACTOR; PREPARATION RICH IN GROWTH FACTOR; THROMBIN; THROMBOCYTE CONCENTRATE; THROMBOCYTE RICH FIBRIN; UNCLASSIFIED DRUG;

BLOOD COMPONENT; COMMERCIAL PHENOMENA; INFLAMMATION; LETTER; NOMENCLATURE; PATENT; THROMBOCYTE LEUKOCYTE GEL; THROMBOCYTE RICH PLASMA;

BLOOD PLATELETS; COMMERCE; FIBRIN; GELS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES; PLATELET-RICH PLASMA; TERMINOLOGY AS TOPIC;

EID: 78449305383     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32894     Document Type: Letter

References (21)

1. Everts PA, van Zundert A, Schonberger JP, Devilee RJ, Knape JT,. What do we use: Platelet-rich plasma or platelet-leukocyte gel? J Biomed Mater Res A 2008; 85: 1135-1136.
2. Anitua E, Sanchez M, Orive G, Andia I,. Shedding light in the controversial terminology for platelet rich products. J Biomed Mater Res A 2009; 90: 1262-1263.
3. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T,. Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009; 27: 158-167.
4. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR,. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 638-646.
5. Bielecki T, Gazdzik TS, Szczepanski T,. Re: "The effects of local platelet rich plasma delivery on diabetic fracture healing". What do we use: Platelet-rich plasma or platelet-rich gel? Bone 2006; 39: 1388.
6. Dohan Ehrenfest DM, Del Corso M, Diss A, Mouhyi J, Charrier JB,. Three-dimensional architecture and cell composition of a Choukroun's platelet-rich fibrin clot and membrane. J Periodontol 2010; 81: 546-555.
7. Fernandez-Barbero JE, Galindo-Moreno P, Avila-Ortiz G, Caba O, Sanchez-Fernandez E, Wang HL,. Flow cytometric and morphological characterization of platelet-rich plasma gel. Clin Oral Implants Res 2006; 17: 687-693.
8. Dohan DM, Choukroun J,. PRP, cPRP, PRF, PRG, PRGF, FC. How to find your way in the jungle of platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 305-306.
9. Schnabel LV, Mohammed HO, Miller BJ, McDermott WG, Jacobson MS, Santangelo KS, Fortier LA,. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res 2007; 25: 230-240.
10. Moojen DJ, Everts PA, Schure RM, Overdevest EP, van Zundert A, Knape JT, Castelein RM, Creemers LB, Dhert WJ,. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res 2008; 26: 404-410.
11. Cieslik-Bielecka A, Gazdzik TS, Bielecki TM, Cieslik T,. Why the platelet-rich gel has antimicrobial activity? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 303-305.
12. Bielecki T, Gazdzik TS, Szczepanski T,. Benefit of percutaneous injection of autologous platelet-leukocyte-rich gel in patients with delayed union and nonunion. Eur Surg Res 2008; 40: 289-296.
13. Cieslik-Bielecka A, Bielecki T, Gazdzik TS, Arendt J, Krol W, Szczepanski T,. Autologous platelets and leukocytes can improve healing of infected high-energy soft tissue injury. Transfus Apher Sci 2009; 41: 9-12.
14. Everts PA, Devilee RJ, Brown Mahoney C, van Erp A, Oosterbos CJ, Stellenboom M, Knape JT, van Zundert A,. Exogenous application of platelet-leukocyte gel during open subacromial decompression contributes to improved patient outcome. A prospective randomized double-blind study. Eur Surg Res 2008; 40: 203-210.
15. Mishra A, Pavelko T,. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 2006; 34: 1774-1778.
16. Dohan Ehrenfest DM, de Peppo GM, Doglioli P, Sammartino G,. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): A gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 2009; 27: 63-69.
17. Dohan Ehrenfest DM, Diss A, Odin G, Doglioli P, Hippolyte MP, Charrier JB,. In vitro effects of Choukroun's PRF (platelet-rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 341-352.
18. Dohan Ehrenfest DM, Doglioli P, de Peppo GM, Del Corso M, Charrier JB,. Choukroun's platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way. Arch Oral Biol 2010; 55: 185-194.
19. Anitua E,. Plasma rich in growth factors: Preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 1999; 14: 529-535.
20. Anitua E, Sanchez M, Orive G, Andia I,. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 2007; 28: 4551-4560.
21. Weibrich G, Kleis WK, A, Hitzler WE, Hafner G,. Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: a technical report. Int J Oral Maxillofac Implants 2005; 20: 118-123.